American College of Cardiology and Medscape
- Recurrent Atypical Chest Pain in a 62-Year-Old Woman
- Hands-on for HF: New Considerations for Cardiac Rehab
- HFpEF: New Treatments Provide 'Hope'
- Is Diabetes a Cardiovascular Risk Equivalent?
- Heart Failure Imaging: Where Are We Now?
- Does Vitamin D Have a Role in Cancer, CVD, and COVID?
- PPCM Management: 5 Things to Know
- Optimal Use of SGLT2 Inhibitors and GLP-1 Agonists
- Hypertrophic Cardiomyopathy Risk Stratification
- Improving Cardiometabolic Health in the COVID-19 Era
- Cancer Therapy and Myocardial Dysfunction: 5 Things to Know
- 2018 AHA/ACC Multisociety Cholesterol Guideline vs 2019 ESC/EAS Dyslipidemia Guidelines
- Cardiologists Should Be More Involved in Treating NAFLD/NASH
- Navigating Prior Authorization and Costs for HFrEF Drugs
- An Expert's Guide to Managing Familial Hypercholesterolemia
- GLP-1 Agonists and SGLT2 Inhibitors in HF Treatment
- Antiplatelet Therapy: Where Do We Stand Now?
- Does the Ketogenic Diet Benefit Patients With Heart Failure?
- CAC Scores, Lp(a), CRP: CV Screening in Real Life
- Remote Monitoring Systems in Heart Failure